Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Zomedica Stock Plunged Today


Shares of Zomedica Pharmaceuticals (NYSEMKT: ZOM) fell 13.7% on Thursday after the veterinary health company announced a change to its sales strategy. 

Zomedica will build out its internal sales team as it transitions away from its current distributor-based approach. CEO Robert Cohen said the move was precipitated by "changes at our current distributor that we believe have impacted its ability to market our products effectively." Those words likely startled investors, many of whom decided to sell their shares.

Zomedica's stock price dropped sharply on Thursday. Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
ZOM
Share

Comments